A comparative study of patoladi kwath and hapushadi yapan vasti in vatarakta

tanushree1 site in 1 country40 target enrollmentStarted: May 28, 2020Last updated: May 22, 2020

Trial Snapshot

Phase: Phase 2
Status: Not yet recruiting
Sponsor
Enrollment: 40
Locations: 1
Primary Endpoint: reduction in subjective parameters according to the specific grading given to each symptoms like burning, pain, skin discoloration, redness, stiffness, tenderness, numbness, heaviness, swelling, deformity in joint involved and pain on joint movement.

Study Overview Study Design Eligibility Criteria Outcomes Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

A total of 40 patients of vatarakta will be selected from opd and ipd of pg department of kayachikitsa uau, gurukul campus, haridwar. The study will be conducted on the patients randomly divided into 2 groups that is 20 patients in each group on the basis of inclusion and exclusion criteria depending on detailed clinical history, physical examination and other necessary and desired investigation. The patients will be followed up at every 15 days after completion of trial.

Study Design

Study Type: Interventional
Allocation: Random Number Table
Masking: Open Label

Eligibility Criteria

Ages: 18.00 Year(s) to 65.00 Year(s) (—)
Sex: All

Inclusion Criteria

•Well diagnosed patients of Vatarakta.
•(Diagnosis will be made on the basis of assessment criteria as mentioned in classical texts & modern medical science.) Both previously treated and fresh cases will be taken.
•Patients of either sex.
•Increased serum uric acid levels of more than 7mg/dl in males and 6mg/dl in females.

Exclusion Criteria

•Patients of Vatarakta with any chronic systemic disorder which interferes with the present study.
•Patients of age below 18 or more than 70 years.
•Patients of Vatarakta having any severe arthritic condition (like R.A.) will be excluded .
•Patients of Vatarakta with conditions like haemarthrosis, Kochâ€™s arthritis, septic arthritis, chronic kidney disease.
•Patients with serious medical illness and psychiatric disorder will be excluded.
•Cases with alcohol dependence/ misuse and drug abuse.

Outcomes

Primary Outcomes

reduction in subjective parameters according to the specific grading given to each symptoms like burning, pain, skin discoloration, redness, stiffness, tenderness, numbness, heaviness, swelling, deformity in joint involved and pain on joint movement.